Current and historical daily PE Ratio for TVTX (
Travere Therapeutics Inc
) from 2003 to May 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Travere Therapeutics stock (TVTX) PE ratio as of May 13 2024 is 0.
More Details
Travere Therapeutics Inc (TVTX) PE Ratio (TTM) Chart
Travere Therapeutics Inc (TVTX) PE Ratio (TTM) Historical Data
View and export this data going back to 2003. Start your Free Trial
Total 1227
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Travere Therapeutics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-05-13 | At Loss | 2024-03-08 | At Loss |
2024-05-10 | At Loss | 2024-03-07 | At Loss |
2024-05-09 | At Loss | 2024-03-06 | At Loss |
2024-05-08 | At Loss | 2024-03-05 | At Loss |
2024-05-07 | At Loss | 2024-03-04 | At Loss |
2024-05-06 | At Loss | 2024-03-01 | At Loss |
2024-05-03 | At Loss | 2024-02-29 | At Loss |
2024-05-02 | At Loss | 2024-02-28 | At Loss |
2024-05-01 | At Loss | 2024-02-27 | At Loss |
2024-04-30 | At Loss | 2024-02-26 | At Loss |
2024-04-29 | At Loss | 2024-02-23 | At Loss |
2024-04-26 | At Loss | 2024-02-22 | At Loss |
2024-04-25 | At Loss | 2024-02-21 | At Loss |
2024-04-24 | At Loss | 2024-02-20 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
2024-04-18 | At Loss | 2024-02-13 | At Loss |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
2024-04-15 | At Loss | 2024-02-08 | At Loss |
2024-04-12 | At Loss | 2024-02-07 | At Loss |
2024-04-11 | At Loss | 2024-02-06 | At Loss |
2024-04-10 | At Loss | 2024-02-05 | At Loss |
2024-04-09 | At Loss | 2024-02-02 | At Loss |
2024-04-08 | At Loss | 2024-02-01 | At Loss |
2024-04-05 | At Loss | 2024-01-31 | At Loss |
2024-04-04 | At Loss | 2024-01-30 | At Loss |
2024-04-03 | At Loss | 2024-01-29 | At Loss |
2024-04-02 | At Loss | 2024-01-26 | At Loss |
2024-04-01 | At Loss | 2024-01-25 | At Loss |
2024-03-28 | At Loss | 2024-01-24 | At Loss |
2024-03-27 | At Loss | 2024-01-23 | At Loss |
2024-03-26 | At Loss | 2024-01-22 | At Loss |
2024-03-25 | At Loss | 2024-01-19 | At Loss |
2024-03-22 | At Loss | 2024-01-18 | At Loss |
2024-03-21 | At Loss | 2024-01-17 | At Loss |
2024-03-20 | At Loss | 2024-01-16 | At Loss |
2024-03-19 | At Loss | 2024-01-12 | At Loss |
2024-03-18 | At Loss | 2024-01-11 | At Loss |
2024-03-15 | At Loss | 2024-01-10 | At Loss |
2024-03-14 | At Loss | 2024-01-09 | At Loss |
2024-03-13 | At Loss | 2024-01-08 | At Loss |
2024-03-12 | At Loss | 2024-01-05 | At Loss |
2024-03-11 | At Loss | 2024-01-04 | At Loss |
Travere Therapeutics Inc (TVTX) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Travere Therapeutics Inc
NAICS : 325411
SIC : 2834
ISIN : US89422G1076
Description